Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes.
Ergun-Longmire B, Marker J, Zeidler A, Rapaport R, Raskin P, Bode B, Schatz D, Vargas A, Rogers D, Schwartz S, Malone J, Krischer J, Maclaren NK.
Ergun-Longmire B, et al. Among authors: schatz d.
Ann N Y Acad Sci. 2004 Dec;1029:260-77. doi: 10.1196/annals.1309.057.
Ann N Y Acad Sci. 2004.
PMID: 15681764
Clinical Trial.